Blood Lactate Levels in Patients Treated With Typical or Atypical Antipsychotics

Completed NCT01139463

Study Description

Blood lactate levels in patients receiving typical or atypical antipsychotics have not been described in the literature. The goal of this study is to assess the dynamics of lactate levels in the blood from typical or atypical antipsychotics not confounded by prior antipsychotic treatments, the investigators conducted a prospective study of lactate levels in patients receiving antipsychotic medication. The investigators hypothesized that 6 months of treatment with haloperidol or olanzapine would result in a change in blood lactate levels and extrapyramidal side effects.

Study Details

Registry ID:
NCT01139463
Conditions:
Movement Disorders, Lactic Acidosis
Phase:
Target Enrollment:
60 participants
Start Date:
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →